Registro:

Referencias:

• Reis-Filho, J.S., Pusztai, L., Gene expression profiling in breast cancer: classification, prognostication, and prediction (2011) Lancet, 378 (9805), pp. 1812-1823
• Goeman, J.J., Bühlmann, P., Analyzing gene expression data interms of gene sets: methodological issues (2007) Bioinformatics, 23 (8), pp. 980-987
• Maciejewski, H., Gene set analysis methods: statistical models and methodological differences (2013) Brief. Bioinforma., , [bbt002]
• Manoli, T., Gretz, N., Gröne, H.-J., Kenzelmann, M., Eils, R., Brors, B., Group testing for pathway analysis improves comparability of di erent microarray datasets (2006) Bioinformatics, 22 (20), pp. 2500-2506
• Pavlidis, P., Qin, J., Arango, V., Mann, J.J., Sibille, E., Using the gene ontology for microarray data mining: a comparison of methods and application to age effects in human prefrontal cortex (2004) Neurochem. Res., 29 (6), pp. 1213-1222
• Huang, D.W., Sherman, B.T., Lempicki, R.A., Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists (2009) Nucleic Acids Res., 37 (1), pp. 1-13
• Subramanian, A., Tamayo, P., Mootha, V.K., Mukherjee, S., Ebert, B.L., Gillette, M.A., Paulovich, A., Lander, E.S., Gene set enrichment analysis: a knowledge based approach for interpreting genome-wide expression pro-les (2005) Proc. Natl. acad. Sci., 102 (43), pp. 15545-15550
• Tian, L., Greenberg, S.A., Kong, S.W., Altschuler, J., Kohane, I.S., Park, P.J., Discovering statistically significant pathways in expression profiling studies, Proceedings of the National Academy of Sciences of the United States of America 102 (38) (2005) 13544–13549; Khatri, P., Sirota, M., Butte, A.J., Ten years of pathway analysis: current approaches and outstanding challenges (2012) PLoS Comput. Biol., 8 (2), p. e1002375
• Ashburner, M., Ball, C.A., Blake, J.A., Botstein, D., Butler, H., Cherry, J.M., Davis, A.P., Eppig, J.T., Gene ontology: tool for the unification of biology (2000) Nat. Genet., 25 (1), pp. 25-29
• Ein-Dor, L., Zuk, O., Domany, E., Thousands of samples are needed to generate a robust gene list for predicting outcome in cancer, Proceedings of the National Academy of Sciences 103 (15) (2006) 5923–5928; Perou, C.M., Sørlie, T., Eisen, M.B., van de Rijn, M., Jeffrey, S.S., Rees, C.A., Pollack, J.R., Akslen, L.A., Molecular portraits of human breast tumours (2000) Nature, 406 (6797), pp. 747-752
• Davis, A.P., Grondin, C.J., Lennon-Hopkins, K., Saraceni-Richards, C., Sciaky, D., King, B.L., Wiegers, T.C., Mattingly, C.J., The comparative toxicogenomics database's 10th year anniversary: update 2015 (2014) Nucleic Acids Res., , [gku935]
• Parker, J.S., Mullins, M., Cheang, M.C., Leung, S., Voduc, D., Vickery, T., Davies, S., Hu, Z., Supervised risk predictor of breast cancer based on intrinsic subtypes (2009) J. Clin. Oncol., 27 (8), pp. 1160-1167
• Gendoo, D.M., Ratanasirigulchai, N., Schröder, M.S., Paré, L., Parker, J.S., Prat, A., Haibe-Kains, B., Genefu: an r/bioconductor package for computation of gene expression-based signatures in breast cancer (2015) Bioinformatics, , [btv693]
• Sørlie, T., Borgan, E., Myhre, S., Vollan, H.K., Russnes, H., Zhao, X., Nilsen, G., Rødland, E., The importance of gene-centring microarray data (2010) Lancet Oncol., 11 (8), pp. 719-720
• Dai, X., Li, T., Bai, Z., Yang, Y., Liu, X., Zhan, J., Shi, B., Breast cancer intrinsic subtype classification, clinical use and future trends (2015) Am. J. Cancer Res., 5 (10), p. 2929
• Ein-Dor, L., Kela, I., Getz, G., Givol, D., Domany, E., Outcome signature genes in breast cancer: is there a unique set? (2005) Bioinformatics, 21 (2), pp. 171-178
• Carlson, M., Falcon, S., Pages, H., Li, N., org. hs. eg. db: Genome wide annotation for human, 2013; Huang, D.W., Sherman, B.T., Lempicki, R.A., Systematic and integrative analysis of large gene lists using david bioinformatics resources (2009) Nat. Protoc., 4 (1), pp. 44-57
• Fresno, C., Fernández, E.A., Rdavidwebservice: a versatile r interface to david (2013) Bioinformatics, , [btt487]
• Falcon, S., Gentleman, R., Using gostats to test gene lists for go term association (2007) Bioinformatics, 23 (2), pp. 257-258
• Fang, H., Gough, J., Thednetapproach promotes emerging research on cancer patient survival (2014) Genome Med., 6 (8), p. 1
• Rivals, I., Personnaz, L., Taing, L., Potier, M.-C., Enrichment or depletion of a go category within a class of genes: which test? (2007) Bioinformatics, 23 (4), pp. 401-407
• Fresno, C., Llera, A.S., Girotti, M.R., Valacco, M.P., López, J.A., Podhajcer, O.L., Balzarini, M.G., Fernández, E.A., The multi-reference contrast method: facilitating set enrichment analysis (2012) Comput. Biol. Med., 42 (2), pp. 188-194
• McCarthy, D.J., Smyth, G.K., Testing significance relative to a fold-change threshold is a treat (2009) Bioinformatics, 25 (6), pp. 765-771
• Berkeley, C., http://www.bepress.com/sagmb/vol3/iss1/art3.[PubMed], Linear models and empirical bayes methods for assessing differential expression in microarray experiments, E-book available at 〈〉; Minn, A.J., Gupta, G.P., Padua, D., Bos, P., Nguyen, D.X., Nuyten, D., Kreike, B., Ishwaran, H., Lung metastasis genes couple breast tumor size and metastatic spread, Proceedings of the National Academy of Sciences 104 (16) (2007) 6740–6745; Wang, Y., Klijn, J.G., Zhang, Y., Sieuwerts, A.M., Look, M.P., Yang, F., Talantov, D., Yu, J., Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer (2005) Lancet, 365 (9460), pp. 671-679
• Van De Vijver, M.J., He, Y.D., van't Veer, L.J., Dai, H., Hart, A.A., Voskuil, D.W., Schreiber, G.J., Marton, M.J., A gene-expression signature as a predictor of survival in breast cancer (2002) New Engl. J. Med., 347 (25), pp. 1999-2009
• Van't Veer, L.J., Dai, H., Van De Vijver, M.J., He, Y.D., Hart, A.A., Mao, M., Peterse, H.L., Witteveen, A.T., Gene expression profiling predicts clinical outcome of breast cancer (2002) Nature, 415 (6871), pp. 530-536
• Desmedt, C., Piette, F., Loi, S., Wang, Y., Lallemand, F., Haibe-Kains, B., Viale, G., d'Assignies, M.S., Strong time dependence of the 76-gene prognostic signature for node-negative breast cancer patients in the transbig multicenter independent validation series (2007) Clin. Cancer Res., 13 (11), pp. 3207-3214
• Miller, K.D., Chap, L.I., Holmes, F.A., Cobleigh, M.A., Marcom, P.K., Fehrenbacher, L., Dickler, M., Sing, A.P., Randomized phase iii trial of capecitabine compared with bevacizumab plus capecitabine in patients with previously treated metastatic breast cancer (2005) J. Clin. Oncol., 23 (4), pp. 792-799
• Sotiriou, C., Wirapati, P., Loi, S., Harris, A., Fox, S., Smeds, J., Nordgren, H., Haibe-Kains, B., Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis (2006) J. Natl. Cancer Inst., 98 (4), pp. 262-272
• Schmidt, M., Böhm, D., von Törne, C., Steiner, E., Puhl, A., Pilch, H., Lehr, H.-A., Gehrmann, M., The humoral immune system has a key prognostic impact in node-negative breast cancer (2008) Cancer Res., 68 (13), pp. 5405-5413
• Mishra, P., Törönen, P., Leino, Y., Holm, L., Gene set analysis: limitations in popular existing methods and proposed improvements (2014) Bioinformatics, 30 (19), pp. 2747-2756
• Oksanen, J., Kindt, R., Legendre, P., OHara, B., Stevens, M.H.H., Oksanen, M.J., Suggests, M., The vegan package, Community ecology package 10; Edelman, E., Porrello, A., Guinney, J., Balakumaran, B., Bild, A., Febbo, P.G., Mukherjee, S., Analysis of sample set enrichment scores: assaying the enrichment of sets of genes for individual samples in genome-wide expression profiles (2006) Bioinformatics, 22 (14), pp. e108-e116
• Ross-Adams, H., Lamb, A., Dunning, M., Halim, S., Lindberg, J., Massie, C., Egevad, L., Vowler, S., Integration of copy number and transcriptomics provides risk stratification in prostate cancer: a discovery and validation cohort study (2015) EBioMedicine, 2 (9), pp. 1133-1144
• Taylor, B.S., Schultz, N., Hieronymus, H., Gopalan, A., Xiao, Y., Carver, B.S., Arora, V.K., Reva, B., Integrative genomic profiling of human prostate cancer (2010) Cancer Cell, 18 (1), pp. 11-22
• Varambally, S., Yu, J., Laxman, B., Rhodes, D.R., Mehra, R., Tomlins, S.A., Shah, R.B., Becich, M.J., Integrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progression (2005) Cancer Cell, 8 (5), pp. 393-406
• Grasso, C.S., Wu, Y.-M., Robinson, D.R., Cao, X., Dhanasekaran, S.M., Khan, A.P., Quist, M.J., Brenner, J.C., The mutational landscape of lethal castration-resistant prostate cancer (2012) Nature, 487 (7406), pp. 239-243
• Rodriguez, J.C., González, G., Fresno, C., Fernández, E.A., Integrative functional analysis improves information retrieval in breast cancer, (2015) Progress in Pattern Recognition, Image Analysis, Computer Vision, and Applications, Springer, pp. 43-50
• Goldhirsch, A., Winer, E.P., Coates, A., Gelber, R., Piccart-Gebhart, M., Thürlimann, B., Senn, H.-J., Bergh, J., Personalizing the treatment of women with early breast cancer: highlights of the st gallen international expert consensus on the primary therapy of early breast cancer 2013 (2013) Ann. Oncol., 24 (9), pp. 2206-2223
• Bastien, R.R., Rodríguez-Lescure, Á., Ebbert, M.T., Prat, A., Munárriz, B., Rowe, L., Miller, P., Lyons, B., Pam50 breast cancer subtyping by rt-qpcr and concordance with standard clinical molecular markers (2012) BMC Med. Genom., 5 (1), p. 1
• Cantor, S.B., Bell, D.W., Ganesan, S., Kass, E.M., Drapkin, R., Grossman, S., Wahrer, D.C., Haber, D.A., Bach1, a novel helicase-like protein, interacts directly with brca1 and contributes to its dna repair function (2001) Cell, 105 (1), pp. 149-160
• Atchley, D.P., Albarracin, C.T., Lopez, A., Valero, V., Amos, C.I., Gonzalez-Angulo, A.M., Hortobagyi, G.N., Arun, B.K., Clinical and pathologic characteristics of patients with brca-positive and brca-negative breast cancer (2008) J. Clin. Oncol., 26 (26), pp. 4282-4288
• Sharma, D., Blum, J., Yang, X., Beaulieu, N., Macleod, A.R., Davidson, N.E., Release of methyl cpg binding proteins and histone deacetylase 1 from the estrogen receptor α (er) promoter upon reactivation in er-negative human breast cancer cells (2005) Mol. Endocrinol., 19 (7), pp. 1740-1751
• Scaltriti, M., Elkabets, M., Baselga, J., Molecular pathways: Axl, a membrane receptor mediator of resistance to therapy, Clinical Cancer Research (2016) clincanres–1458

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------